CC
ETON icon

Cannell Capital’s Eton Pharmaceutcials ETON Stock Holding History

Cannell Capital’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.44M Buy
341,985
+125,068
+58% +$2.19M 5.18% 5
2025
Q4 		$3.67M Sell
216,917
-238,488
-52% -$4.2M 1.78% 22
2025
Q3 		$9.9M Buy
455,405
+67,230
+17% +$1.12M 1.51% 12
2025
Q2 		$5.53M Sell
388,175
-303,192
-44% -$4.79M 1.65% 24
2025
Q1 		$8.97M Buy
691,367
+310,044
+81% +$4.68M 2.99% 12
2024
Q4 		$5.08M Buy
+381,323
New +$3.87M 1.04% 28

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Cannell Capital's ETON Position: Q1 2026 in Review

Cannell Capital increased its Eton Pharmaceutcials (ETON) stake by 58% in Q1 2026, buying an estimated $2.19M and bringing the position to 341,985 shares worth $8.44M. The position accounts for 5.18% of the portfolio, ranked #5.

Cannell Capital first reported a position in ETON in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.9M in Q3 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Cannell Capital held 341,985 shares of Eton Pharmaceutcials worth $8.44M as of Q1 2026.
  • Cannell Capital bought 125,068 Eton Pharmaceutcials shares in Q1 2026, an estimated $2.19M.
  • Eton Pharmaceutcials made up 5.18% of Cannell Capital's portfolio in Q1 2026, its #5 holding.
  • Cannell Capital first reported a position in Eton Pharmaceutcials in Q4 2024 and has held it in 6 quarters since.
  • Cannell Capital's Eton Pharmaceutcials position peaked at $9.9M in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Cannell Capital's 13F filing for Q1 2026, filed 15 May 2026.